Back to Search
Start Over
A newly described cutaneous reaction at sites of insulin pump use in a child with Type 1 diabetes
- Source :
- Pediatric Dermatology. 38:239-241
- Publication Year :
- 2020
- Publisher :
- Wiley, 2020.
-
Abstract
- Continuous subcutaneous insulin infusion (CSII), or insulin pumps, with or without continuous glucose monitoring (CGM) devices have become the standard of care for patients with type 1 diabetes. While increasingly popular, a wide range of reported skin reactions to CSII and CGM devices was found. We present this case of a pyogenic granuloma-like neutrophilic and granulomatous response to an insulin pump to increase awareness of a previously uncharacterized cutaneous adverse reaction at insulin pump infusion sites.
- Subjects :
- Insulin pump
medicine.medical_specialty
Type 1 diabetes
Standard of care
Continuous glucose monitoring
business.industry
Insulin
medicine.medical_treatment
Dermatology
medicine.disease
Subcutaneous insulin
030207 dermatology & venereal diseases
03 medical and health sciences
Skin reaction
0302 clinical medicine
Endocrinology
030220 oncology & carcinogenesis
Internal medicine
Pediatrics, Perinatology and Child Health
medicine
Adverse effect
business
Subjects
Details
- ISSN :
- 15251470 and 07368046
- Volume :
- 38
- Database :
- OpenAIRE
- Journal :
- Pediatric Dermatology
- Accession number :
- edsair.doi...........7799c1cefb3730f752898ed4f4e2a808